Jump to main content
Jump to site search

Issue 8, 2017
Previous Article Next Article

Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity

Author affiliations

Abstract

Unusual patterns of glycosylation on the surface of transformed cells contribute to immune modulation and metastasis of malignant tumors. Active immunization against them requires effective antigen presentation, which is complicated by a lack of access to tumor-specific posttranslational modifications through standard genetic approaches and by the low efficiency of passive antigen sampling. We found that antigen targeted to antigen presenting cells via class II MHC products can elicit a robust immune response against MUC1(Tn) bearing a defined tumor-associated glycoform, Tn. The two-component vaccine construct was prepared by sortase-mediated protein ligation of a synthetic MUC1(Tn) fragment to a class II MHC-binding single-domain antibody fragment (VHH7) as targeting moiety. We show that VHH7 targets antigen presenting cells in vivo, and when conjugated to MUC1(Tn) can elicit a strong αMUC1(Tn) immune response in mice. The resulting sera preferentially recognized the MUC1 epitope with the tumor-associated carbohydrate antigen Tn and were capable of killing cancer cells in a complement-mediated cytotoxicity assay. Immunoglobulin isotype analysis and cytokine release assays suggested a favorable Th1 response. A single boost 12 months after primary immunization triggered a recall response of the same quality, suggesting that long-term αMUC1(Tn) memory had been achieved.

Graphical abstract: Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity

Back to tab navigation

Supplementary files

Publication details

The article was received on 30 Jan 2017, accepted on 23 May 2017 and first published on 26 May 2017


Article type: Edge Article
DOI: 10.1039/C7SC00446J
Citation: Chem. Sci., 2017,8, 5591-5597
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity

    T. Fang, C. H. M. J. Van Elssen, J. N. Duarte, J. S. Guzman, J. S. Chahal, J. Ling and H. L. Ploegh, Chem. Sci., 2017, 8, 5591
    DOI: 10.1039/C7SC00446J

    This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements